Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantitative Xylazine Measurement Among Non-Fatal Opioid Overdose Patients in the Emergency Department

NCT06949605 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.

NCT NCT06949605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06949605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantitative Xylazine Measurement Among Non-Fatal Opioid Overdose Patients in the Emergency Department
Lead sponsor
Icahn School of Medicine at Mount Sinai
Phase
Observational
Overall status
Completed
Start date
April 1, 2025
Completion date
February 28, 2026
Enrollment
75 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

opioid overdose, substance use disorders